Skip to content
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文（繁體）
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Language
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
Future of flu vaccines. Expedi...
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Permanent link
Future of flu vaccines. Expediting clinical trials in a pandemic.
Show other versions (1)
Bibliographic Details
Main Authors:
Pollard, A
,
Reiner, A
,
John, T
,
Sheasby, E
,
Snape, M
,
Faust, S
,
Collinson, A
,
Finn, A
,
Heath, P
,
Miller, E
Format:
Journal article
Language:
English
Published:
2009
Holdings
Description
Other Versions (1)
Similar Items
Staff View
Similar Items
Future of flu vaccines. Expediting clinical trials in a pandemic.
by: Pollard, A, et al.
Published: (2009)
Relationships between reactogenicity and age, dose number and immunogenicity in 937 children receiving two doses of ASO3(B)-adjuvanted split virion or whole virus H1N1 influenza A 2009 pandemic vaccines
by: Walker, W, et al.
Published: (2011)
Safety and immunogenicity of AS03 B adjuvanted split virion versus non-adjuvanted whole virion H1N1 influenza vaccine in UK children aged 6 months-12 years: Open label, randomised, parallel group, multicentre study
by: Waddington, C, et al.
Published: (2010)
Safety and immunogenicity of AS03B adjuvanted split virion versus non-adjuvanted whole virion H1N1 influenza vaccine in UK children aged 6 months-12 years: open label, randomised, parallel group, multicentre study.
by: Waddington, C, et al.
Published: (2010)
Pandemic vaccine trials: expedite, but don’t rush
by: Angus Dawson
Published: (2020-07-01)